BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 31110135)

  • 1. Characteristics of Waveform Shape in Parkinson's Disease Detected with Scalp Electroencephalography.
    Jackson N; Cole SR; Voytek B; Swann NC
    eNeuro; 2019; 6(3):. PubMed ID: 31110135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonsinusoidal Beta Oscillations Reflect Cortical Pathophysiology in Parkinson's Disease.
    Cole SR; van der Meij R; Peterson EJ; de Hemptinne C; Starr PA; Voytek B
    J Neurosci; 2017 May; 37(18):4830-4840. PubMed ID: 28416595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatiotemporal features of β-γ phase-amplitude coupling in Parkinson's disease derived from scalp EEG.
    Gong R; Wegscheider M; Mühlberg C; Gast R; Fricke C; Rumpf JJ; Nikulin VV; Knösche TR; Classen J
    Brain; 2021 Mar; 144(2):487-503. PubMed ID: 33257940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated synchrony in Parkinson disease detected with electroencephalography.
    Swann NC; de Hemptinne C; Aron AR; Ostrem JL; Knight RT; Starr PA
    Ann Neurol; 2015 Nov; 78(5):742-50. PubMed ID: 26290353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synchrony Drives Motor Cortex Beta Bursting, Waveform Dynamics, and Phase-Amplitude Coupling in Parkinson's Disease.
    O'Keeffe AB; Malekmohammadi M; Sparks H; Pouratian N
    J Neurosci; 2020 Jul; 40(30):5833-5846. PubMed ID: 32576623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pallidal Deep-Brain Stimulation Disrupts Pallidal Beta Oscillations and Coherence with Primary Motor Cortex in Parkinson's Disease.
    Wang DD; de Hemptinne C; Miocinovic S; Ostrem JL; Galifianakis NB; San Luciano M; Starr PA
    J Neurosci; 2018 May; 38(19):4556-4568. PubMed ID: 29661966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of synchronized dynamics in cortex and basal ganglia in Parkinson's disease.
    Ahn S; Zauber SE; Worth RM; Witt T; Rubchinsky LL
    Eur J Neurosci; 2015 Sep; 42(5):2164-71. PubMed ID: 26154341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of levodopa on electroencephalographic biomarkers of the parkinsonian state.
    Miller AM; Miocinovic S; Swann NC; Rajagopalan SS; Darevsky DM; Gilron R; de Hemptinne C; Ostrem JL; Starr PA
    J Neurophysiol; 2019 Jul; 122(1):290-299. PubMed ID: 31066605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetoencephalography detects phase-amplitude coupling in Parkinson's disease.
    Tanaka M; Yanagisawa T; Fukuma R; Tani N; Oshino S; Mihara M; Hattori N; Kajiyama Y; Hashimoto R; Ikeda M; Mochizuki H; Kishima H
    Sci Rep; 2022 Feb; 12(1):1835. PubMed ID: 35115607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormally low sensorimotor α band nonlinearity serves as an effective EEG biomarker of Parkinson's disease.
    Özkurt TE
    J Neurophysiol; 2024 Feb; 131(2):435-445. PubMed ID: 38230880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal biomarkers of Parkinson's disease are present in healthy aging.
    Zhang J; Idaji MJ; Villringer A; Nikulin VV
    Neuroimage; 2021 Nov; 243():118512. PubMed ID: 34455060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive timing functions of cortical beta oscillations are impaired in Parkinson's disease and influenced by L-DOPA and deep brain stimulation of the subthalamic nucleus.
    Gulberti A; Moll CK; Hamel W; Buhmann C; Koeppen JA; Boelmans K; Zittel S; Gerloff C; Westphal M; Schneider TR; Engel AK
    Neuroimage Clin; 2015; 9():436-49. PubMed ID: 26594626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated Gaussian-modeled beta power in the cortex characterizes aging, but not Parkinson's disease.
    Karekal A; Stuart S; Mancini M; Swann NC
    J Neurophysiol; 2023 May; 129(5):1086-1093. PubMed ID: 37017333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypersynchrony despite pathologically reduced beta oscillations in patients with Parkinson's disease: a pharmaco-magnetoencephalography study.
    Heinrichs-Graham E; Kurz MJ; Becker KM; Santamaria PM; Gendelman HE; Wilson TW
    J Neurophysiol; 2014 Oct; 112(7):1739-47. PubMed ID: 25008416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subthalamic local field potentials in Parkinson's disease and isolated dystonia: An evaluation of potential biomarkers.
    Wang DD; de Hemptinne C; Miocinovic S; Qasim SE; Miller AM; Ostrem JL; Galifianakis NB; San Luciano M; Starr PA
    Neurobiol Dis; 2016 May; 89():213-22. PubMed ID: 26884091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruptions of cortico-kinematic interactions in Parkinson's disease.
    McLinden J; Deligani RJ; Abtahi MR; Akbar U; Mankodiya K; Shahriari Y
    Behav Brain Res; 2021 Apr; 404():113153. PubMed ID: 33571571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A shift from prospective to reactive modulation of beta-band oscillations in Parkinson's disease.
    te Woerd ES; Oostenveld R; de Lange FP; Praamstra P
    Neuroimage; 2014 Oct; 100():507-19. PubMed ID: 24969569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptive grip force is modulated by subthalamic beta activity in Parkinson's disease patients.
    Imbach LL; Baumann-Vogel H; Baumann CR; Sürücü O; Hermsdörfer J; Sarnthein J
    Neuroimage Clin; 2015; 9():450-7. PubMed ID: 26594627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Movement-related dynamics of cortical oscillations in Parkinson's disease and essential tremor.
    Kondylis ED; Randazzo MJ; Alhourani A; Lipski WJ; Wozny TA; Pandya Y; Ghuman AS; Turner RS; Crammond DJ; Richardson RM
    Brain; 2016 Aug; 139(Pt 8):2211-23. PubMed ID: 27329771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased SMA-M1 coherence in Parkinson's disease - Pathophysiology or compensation?
    Pollok B; Kamp D; Butz M; Wojtecki L; Timmermann L; Südmeyer M; Krause V; Schnitzler A
    Exp Neurol; 2013 Sep; 247():178-81. PubMed ID: 23664959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.